Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.

NCT06434753 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Advanced Chronic Liver Disease
Portal Hypertension
Hepatocellular Carcinoma

Interventions

DRUG: Zinc Acexamate

Sponsor

Hospital Universitari Vall d'Hebron Research Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]